[go: up one dir, main page]

DE60321572D1 - Transdermales arzneimittelverabreichungssystem - Google Patents

Transdermales arzneimittelverabreichungssystem

Info

Publication number
DE60321572D1
DE60321572D1 DE60321572T DE60321572T DE60321572D1 DE 60321572 D1 DE60321572 D1 DE 60321572D1 DE 60321572 T DE60321572 T DE 60321572T DE 60321572 T DE60321572 T DE 60321572T DE 60321572 D1 DE60321572 D1 DE 60321572D1
Authority
DE
Germany
Prior art keywords
drug administration
transdermal drug
administration system
transdermal
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60321572T
Other languages
English (en)
Inventor
Amnon Sintov
Raphael Gorodischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL150334A external-priority patent/IL150334A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60321572D1 publication Critical patent/DE60321572D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60321572T 2002-06-20 2003-06-16 Transdermales arzneimittelverabreichungssystem Expired - Lifetime DE60321572D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL150334A IL150334A (en) 2000-07-27 2002-06-20 A system for administering drugs through the skin
PCT/IL2003/000513 WO2004000358A1 (en) 2002-06-20 2003-06-16 Transdermal drug delivery system

Publications (1)

Publication Number Publication Date
DE60321572D1 true DE60321572D1 (de) 2008-07-24

Family

ID=29798316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60321572T Expired - Lifetime DE60321572D1 (de) 2002-06-20 2003-06-16 Transdermales arzneimittelverabreichungssystem

Country Status (6)

Country Link
US (1) US20050226910A1 (de)
EP (1) EP1517709B1 (de)
AU (1) AU2003241134A1 (de)
CA (1) CA2489347A1 (de)
DE (1) DE60321572D1 (de)
WO (1) WO2004000358A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
US20060115522A1 (en) * 2003-02-17 2006-06-01 Cipla Ltd Pharmaceutical composition
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US20060210613A1 (en) * 2005-03-15 2006-09-21 Carliss Richard D Therapeutic wound care product
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
FR2901702A1 (fr) * 2006-05-31 2007-12-07 Galderma Res & Dev S N C Snc Utilisation de granisetron pour le traitement de sous-types de la rosacee, et compositions pharmaceutiques
WO2008011161A2 (en) 2006-07-21 2008-01-24 Bridge Pharma, Inc. Dermal anesthetic compounds
MX2011003510A (es) 2008-10-02 2011-06-17 Mylan Inc Metodo para fabricar un laminado adhesivo de multiples capas.
KR101101321B1 (ko) * 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
US9012477B2 (en) * 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
EP2523660A4 (de) 2010-01-14 2013-07-10 Nuvo Res Inc Bildung fester formen von lokalanästhesieformulierungen zur schmerzbekämpfung
WO2013138520A1 (en) * 2012-03-13 2013-09-19 University Of Tennessee Research Foundation Composition and system for transdermal delivery

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2087721B (en) * 1980-11-20 1984-01-25 Beecham Group Ltd Injectable antibiotic formulations stabilised with glycofurol
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
EP0639068A1 (de) * 1992-05-05 1995-02-22 The Procter & Gamble Company Aknebahandlungsmittel
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
IL118235A0 (en) * 1996-05-13 1996-09-12 Univ Ben Gurion Composition and method for forming biodegradable implants in situ and uses of these implants
IT1291362B1 (it) * 1997-05-13 1999-01-07 Vectorpharma Int Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
IL135222A (en) * 2000-03-22 2005-06-19 Univ Ben Gurion Compositions containing molecular iodine
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin

Also Published As

Publication number Publication date
WO2004000358B1 (en) 2004-03-25
US20050226910A1 (en) 2005-10-13
EP1517709A1 (de) 2005-03-30
AU2003241134A1 (en) 2004-01-06
EP1517709B1 (de) 2008-06-11
WO2004000358A1 (en) 2003-12-31
CA2489347A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
DK1545662T3 (da) Lægemiddelindgivelsessystem
NO20053224D0 (no) Patient controlled drug administration device.
DK1599186T3 (da) System til administration af transmukalt lægemiddel
ATE526973T1 (de) Verbesserte arzneimittelabgabe in transdermalen systemen
DK1635875T3 (da) In-situ-geldannende lægemiddeladministrationssystem
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
NO20053150D0 (no) System for administrasjon av medisin.
DE60308372D1 (de) Dosierungsverabreichungsvorrichtung
EP1620118A4 (de) Reversible pegylierte arzneimittel
IS7946A (is) Lyf
NO20041315L (no) Medikamentavleveringssystem
EP1469812A4 (de) Orale insulintherapie
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
PT102854B (pt) Sistema de aplicacao de medicamento bioadesivo
DE602004017700D1 (de) Transmukosen verabreichung
AT10108U3 (de) Fentanyl-hältiges, transdermales, therapeutisches system
IL169083A (en) Medication administration system
ATE551051T1 (de) Orales arzneimittelabgabesystem
DE60321572D1 (de) Transdermales arzneimittelverabreichungssystem
AU2003212962A8 (en) Transdermal drug delivery systems
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
DE602004025444D1 (de) Transdermales therapeutisches System von Gestoden
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
ITMI20022658A1 (it) Farmaci per il dolore cronico.
ITMI20020921A1 (it) Dispositivo per la sommistrazione di farmaci

Legal Events

Date Code Title Description
8364 No opposition during term of opposition